“Age Reversal Is Coming.” Inside The First Human Trials - Dr David Sinclair - #1141

Aging is a treatable disease characterized by the corruption of epigenetic software, which can be reversed by resetting cellular information. Dr. David Sinclair, a leading researcher in longevity, explains that Yamanaka factors—specifically a subset that avoids cellular identity loss—can rejuvenate tissues and potentially cure age-related conditions like blindness. Beyond gene therapy, Sinclair highlights the efficacy of fasting, exercise, and specific supplements like NAD precursors and resveratrol in activating survival pathways that stabilize the epigenome. While the field moves toward human trials, Sinclair emphasizes that lifestyle factors such as intermittent fasting, resistance training, and stress management remain foundational. Emerging AI-driven research is accelerating drug discovery, moving the field closer to a single-molecule solution for systemic age reversal, challenging the traditional view of aging as an inevitable biological decline.